Excelitas Technologies Names New CEO and CFO

2023-10-30
高管变更
Excelitas Technologies Corp., an industrial technology manufacturer and the parent company of Phoseon Technologies, has announced the appointment of Ron Keating as its new chief executive officer and Ben Stas as chief financial officer. Keating and Stas succeed former CEO David Nislick and former CFO Jim Rao who have announced their retirements. “Nearly 20 years ago, I joined Excelitas, the past 13 of which I had the privilege of serving as its CEO,” says David Nislick. “I am most proud of the culture Jim Rao and I have built, the thousands of employees across the globe who have joined our community and the significant value we have created with the entire Excelitas team for our shareholders. Jim and I are both committed to ensuring a smooth transition and have committed time to support new leadership,” added Nislick, who will remain on the Excelitas Board of Directors as an independent director. “Our Board of Directors would like to thank David Nislick and Jim Rao for their steadfast leadership. Over the last 13 years, David and Jim have built Excelitas into a leading industrial technology company,” said Vinay Kumar, board member and partner of AEA Investors. “We have known Ron Keating and Ben Stas for over a decade and believe they can accelerate the success of Excelitas as it enters a new phase.” Keating served the past nine years as president and CEO at Evoqua Water Technologies, which he took public in 2017. This past year, he successfully led the sale of Evoqua to Xylem. Stas served alongside Keating at Evoqua as the EVP, CFO and treasurer. The two also worked closely together at Kennametal, where they served in leadership positions before moving to Evoqua. “Ben and I are honored to join the Excelitas team as we embark on an exciting future for the company,” says Keating. “With a strong foundation created by David Nislick and Jim Rao, and its best-in-class technologies delivered by a best-in-class team, Excelitas is poised for growth and sustainable success.” In moving forward in their new capacities, Keating and Stas pledged to build on Excelitas’ strengths, on delivering exceptional value to customers and on remaining steadfast to the company’s values and commitment to employee wellbeing and safety. The two plan an aggressive schedule of visiting many of Excelitas’ sites over the coming weeks and months.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。